US4064227A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Radioimmunoassay method for the determination of cardiotonic glycosides
Assignee: BYK-Sangtec Diagnostica GmbH and Co KG
•
Filing: 1975-03-17
•
Granted: 1977-12-20
•
Expires: 1995-03-17
Abstract
Abstract An improved, simplified radioimmunoassay method for the in vitro determination of cardiotonic glycosides in unextracted blood serum involves the use of a reagent constituting a buffer solution containing a radioactive hapten for such glycosides. Packaged test kits for use in conveniently carrying out the radioimmunoassay are also provided.
Inventors
- 👤 James L. Brown
- 👤 Leo R. Lyle
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 10:00
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/94; G01N33/9453; Y; Y10; Y10S; Y10S436/00; Y10S436/804; Y10S436/811; Y10S436/815; Y10S436/817
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
177 words
A radioimmunoassay method for the in vitro determination of a cardiotonic glycoside selected from the group consisting of digoxin and digitoxin in unextracted blood serum which comprises the steps of a. mixing a sample of blood serum whose cardiotonic glycoside content is to be determined with a reagent comprising an aqueous buffer solution containing a radioactive hapten for said glycoside; b. adding to the mixure in an amount by volume equal to the amount by volume of the sample of blood serum an antiserum containing antibody capable of immunoreactivity with said glycoside and said hapten; c. incubating the resultant mixture at a temperature and for a sufficient period of time to produce substantial equilibration of the antibody bound hapten and unbound hapten; d. adding a relatively thin strip of a membrane consisting essentially of an ion-exchange resin to the mixture and maintaining said membrane in contact therewith at a temperature and for a sufficient period of time to separate the unbound hapten; and e. determining the relative amounts of antibody bound radioactive hapten and unbound radioactive hapten.
Claim 2
Dependent Claim
177 words
A radioimmunoassay method for the in vitro determination of a cardiotonic glycoside selected from the group consisting of digoxin and digitoxin in unextracted blood serum which comprises the steps of a. mixing a sample of blood serum whose cardiotonic glycoside content is to be determined with a reagent comprising an aqueous buffer solution containing a radioactive hapten for said glycoside; b. adding to the mixure in an amount by volume equal to the amount by volume of the sample of blood serum an antiserum containing antibody capable of immunoreactivity with said glycoside and said hapten; c. incubating the resultant mixture at a temperature and for a sufficient period of time to produce substantial equilibration of the antibody bound hapten and unbound hapten; d. adding a relatively thin strip of a membrane consisting essentially of an ion-exchange resin to the mixture and maintaining said membrane in contact therewith at a temperature and for a sufficient period of time to separate the unbound hapten; and e. determining the relative amounts of antibody bound radioactive hapten and unbound radioactive hapten.
Claim 3
Dependent Claim
36 words
A method according to claim 1 wherein said hapten is radioactive I-125 3-succinyl digoxigenin-L-tyrosine, radioactive I-125 3-succinyl digitoxigenin tyrosine, radioactive I-125 3-adipyl digoxigenin tyrosine, radioactive I-125 3-adipyl digitoxigenin tyrosine, radioactive I-125 3-carbodigoxigenin-glycyl-L-tyrosine, or radioactive I-125 3-carbodigitoxigenin-L-tyrosine.
Claim 4
Dependent Claim
28 words
A method according to claim 2, wherein said incubation step is carried out at a temperature of 20° to 24° C. for a period of approximately 30 minutes.
Claim 5
Dependent Claim
28 words
A method according to claim 3 wherein said mixture is maintained in contact with said membrane for a period of approximately 30 to 60 minutes at room temperature.
Claim 6
Dependent Claim
25 words
A method according to claim 4 wherein said cardiotonic glycoside to be determined is digoxin and said radioactive hapten is radioactive I-125 3-adipyl digoxigen tyrosine.
Claim 7
Dependent Claim
92 words
A radioimmunoassay method for the in vitro determination of digoxin in unextracted blood serum which comprises the steps of a. mixing a sample of blood serum whose digoxin content is to be determined with a reagent comprising an aqeuous buffer solution containing the radioactive I-125 3-adipyl digoxigenin tyrosine hapten; b. mixing with said reagent a digitoxigenin standard containing a known quantity of digoxin in serum, provided that the amount by volume of said digoxin standard mixed with said reagent is equal to the amount by volume of the sample of blood serum.
Claim 8
Dependent Claim
92 words
A radioimmunoassay method for the in vitro determination of digoxin in unextracted blood serum which comprises the steps of a. mixing a sample of blood serum whose digoxin content is to be determined with a reagent comprising an aqeuous buffer solution containing the radioactive I-125 3-adipyl digoxigenin tyrosine hapten; b. mixing with said reagent a digitoxigenin standard containing a known quantity of digoxin in serum, provided that the amount by volume of said digoxin standard mixed with said reagent is equal to the amount by volume of the sample of blood serum.
Claim 9
Dependent Claim
134 words
1 c. adding to each of the mixtures in an amount by volume equal to the amount by volume of the sample of blood serum an antiserum containing antibody capable of immuno reactivity with said digoxin and said hapten; d. incubating the resultant mixtures at approximately room temperature for a period of about 20 to 35 minutes to produce substantial equilibration of the anitbody bound hapten and unbound hapten; e. adding a relatively thin strip of a membrane consisting essentially of an ion exchange resin to each of the mixtures and maintaining said membrane in contact therewith at approximately room temperature for a period of 30 to 60 minutes to separate the unbound hapten from the antibody bound hapten; and f. determining the relative amounts of antibody bound radioactive hapten and unbound radioactive hapten.
Claim 10
Dependent Claim
134 words
1 c. adding to each of the mixtures in an amount by volume equal to the amount by volume of the sample of blood serum an antiserum containing antibody capable of immuno reactivity with said digoxin and said hapten; d. incubating the resultant mixtures at approximately room temperature for a period of about 20 to 35 minutes to produce substantial equilibration of the anitbody bound hapten and unbound hapten; e. adding a relatively thin strip of a membrane consisting essentially of an ion exchange resin to each of the mixtures and maintaining said membrane in contact therewith at approximately room temperature for a period of 30 to 60 minutes to separate the unbound hapten from the antibody bound hapten; and f. determining the relative amounts of antibody bound radioactive hapten and unbound radioactive hapten.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-12-19 | 1981-06-20 | 1981-12-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-12-19 | 1985-06-20 | 1985-12-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-12-19 | 1989-06-20 | 1989-12-20 | $7700.00 | Window Closed / Lapsed |